Harmony Biosciences Holdings, Inc. (HRMY)
Harmony Biosciences Holdings, Inc. (HRMY)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 589,398 | 752,502 | 646,999 | 546,050 |
| Investments, short-term | 51,520 | 22,838 | 25,582 | 19,224 |
| Trade receivables, net | 108,222 | 96,787 | 100,651 | 92,981 |
| Inventory, net | 5,281 | 5,357 | 6,882 | 6,100 |
| Prepaid expenses | 16,801 | 16,014 | 23,308 | 18,363 |
| Other current assets | 7,595 | 13,516 | 35,378 | 8,636 |
| Restricted cash | NaN | NaN | NaN | 270 |
| Total current assets | 778,817 | 907,014 | 838,800 | 691,354 |
| Property and equipment, net | NaN | NaN | 1,440 | 1,376 |
| Investments, long-term | 229,555 | 107,127 | 105,831 | 107,008 |
| Intangible assets, net | 83,457 | 89,418 | 95,380 | 101,341 |
| Deferred tax asset | 153,562 | 149,699 | 157,075 | 201,194 |
| Other noncurrent assets | 26,433 | 18,373 | 9,692 | 5,465 |
| Total noncurrent assets | 493,007 | 364,617 | 369,418 | 416,654 |
| Total assets | 1,271,824 | 1,271,631 | 1,208,218 | 1,108,008 |
| Trade payables | 28,600 | 17,693 | 26,341 | 28,301 |
| Accrued compensation | 6,726 | 18,443 | 14,935 | 11,735 |
| Accrued expenses | 150,107 | 191,039 | 161,302 | 118,293 |
| Current portion of long-term debt | 20,000 | 20,000 | 20,000 | 18,750 |
| Other current liabilities | 11,907 | 4,957 | 825 | 3,056 |
| Total current liabilities | 217,340 | 252,132 | 223,403 | 180,135 |
| Long-term debt, net | 138,814 | 143,663 | 148,506 | 153,345 |
| Other noncurrent liabilities | 5,321 | 5,618 | 1,186 | 1,448 |
| Total noncurrent liabilities | 144,135 | 149,281 | 149,692 | 154,793 |
| Total liabilities | 361,475 | 401,413 | 373,095 | 334,928 |
| Common stock-0.00001 par value 500,000,000 shares authorized at march 31, 2026 and december 31, 2025, respectively 57,867,389 and 57,726,170 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 1 | 1 | 1 | 1 |
| Additional paid in capital | 717,370 | 708,968 | 696,348 | 685,288 |
| Accumulated other comprehensive income | -413 | 346 | 357 | 239 |
| Retained earnings | 193,391 | 160,903 | 138,417 | 87,552 |
| Total stockholders' equity | 910,349 | 870,218 | 835,123 | 773,080 |
| Total liabilities and stockholders' equity | 1,271,824 | 1,271,631 | 1,208,218 | 1,108,008 |